🇺🇸 Metformin IR in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 11

Most-reported reactions

1. Diarrhoea — 2 reports (18.18%)
2. Confusional State — 1 report (9.09%)
3. Dizziness — 1 report (9.09%)
4. Drug Dispensing Error — 1 report (9.09%)
5. Dyspepsia — 1 report (9.09%)
6. Erosive Oesophagitis — 1 report (9.09%)
7. Fall — 1 report (9.09%)
8. Flatulence — 1 report (9.09%)
9. Incorrect Dosage Administered — 1 report (9.09%)
10. Lethargy — 1 report (9.09%)

Source database →

Frequently asked questions

Is Metformin IR approved in United States?

Metformin IR does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Metformin IR in United States?

AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.